179 related articles for article (PubMed ID: 22747609)
21. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
22. Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes.
Pal S; Bi Y; Macyszyn L; Showe LC; O'Rourke DM; Davuluri RV
Nucleic Acids Res; 2014 Apr; 42(8):e64. PubMed ID: 24503249
[TBL] [Abstract][Full Text] [Related]
23. Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.
Korshunov A; Chavez L; Sharma T; Ryzhova M; Schrimpf D; Stichel D; Capper D; Sturm D; Kool M; Habel A; Kleinschmidt-DeMasters BK; Rosenblum M; Absalyamova O; Golanov A; Lichter P; Pfister SM; Jones DTW; Perry A; von Deimling A
Brain Pathol; 2018 Sep; 28(5):656-662. PubMed ID: 28990704
[TBL] [Abstract][Full Text] [Related]
24. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
25. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
27. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.
Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X
Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531
[TBL] [Abstract][Full Text] [Related]
28. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
Lu J; Cowperthwaite MC; Burnett MG; Shpak M
PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
Patil V; Mahalingam K
Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of MGMT methylation and expression of MGMT, P53, EGFR, MDM2 and PTEN in glioblastoma multiforme.
Limam S; Missaoui N; Abdessayed N; Mestiri S; Selmi B; Mokni M; Yacoubi MT
Ann Biol Clin (Paris); 2019 Jun; 77(3):307-317. PubMed ID: 31131831
[TBL] [Abstract][Full Text] [Related]
31. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
32. Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.
Hoffman DI; Abdullah KG; McCoskey M; Binder ZA; O'Rourke DM; Desai AS; Nasrallah MP; Bigdeli A; Morrissette JJD; Brem S; Bagley SJ
J Neurooncol; 2019 Nov; 145(2):321-328. PubMed ID: 31542863
[TBL] [Abstract][Full Text] [Related]
33. Role of Wnt5a in the proliferation of human glioblastoma cells.
Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS
Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179
[TBL] [Abstract][Full Text] [Related]
34. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
35. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Zhang J; Xiao X; Zhang X; Hua W
J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
[TBL] [Abstract][Full Text] [Related]
36. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
37. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.
Newcomb EW; Cohen H; Lee SR; Bhalla SK; Bloom J; Hayes RL; Miller DC
Brain Pathol; 1998 Oct; 8(4):655-67. PubMed ID: 9804374
[TBL] [Abstract][Full Text] [Related]
38. Expression and clinical significance of CPS1 in glioblastoma multiforme.
Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z
Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588
[TBL] [Abstract][Full Text] [Related]
39. Subclassification of newly diagnosed glioblastomas through an immunohistochemical approach.
Conroy S; Kruyt FA; Joseph JV; Balasubramaniyan V; Bhat KP; Wagemakers M; Enting RH; Walenkamp AM; den Dunnen WF
PLoS One; 2014; 9(12):e115687. PubMed ID: 25546404
[TBL] [Abstract][Full Text] [Related]
40. Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma.
Ma X; Yoshimoto K; Guan Y; Hata N; Mizoguchi M; Sagata N; Murata H; Kuga D; Amano T; Nakamizo A; Sasaki T
Neuro Oncol; 2012 Sep; 14(9):1153-62. PubMed ID: 22844109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
